Roche India
May 17, 2012 at 12:28 | Source: CNBC
May 04, 2012 at 13:45 | Source: CNBC-TV18
Mar 23, 2012 at 11:56 | Source: Reuters
Mar 23, 2012 at 10:12 | Source: Reuters
Jan 13, 2012 at 19:00 | Source: Reuters
Nov 02, 2011 at 21:36 | Source: CNBC-TV18
Interact & exchange stock tips & market info »
Related News »
LONDON (Reuters) - Two experimental skin cancer drugs from GlaxoSmithKline - each designed to block different pathways used by tumour cells - look set to steal a march on Roche's pioneering melanoma treatment Zelboraf, according to Citigroup. The brokerage ...
May 28, 2012 at 11:57 | Source: in.news.yahoo.com
These drugs are not covered under India’s drug price control order because they are new drugs. And there was largely no competition due to patent protection. But in 2009, Cipla launched a copy of Roche’s Tarceva (erlotinib), challenging the foreign ...
May 8, 2012 at 18:04 | Source: Livemint.com
But David Roche, Global Strategist at Independent Strategy ... “Central banks have started to try and stem some of the outflows. India was the most active but we are seeing some catch up.” After the recent selloff, some currencies are undervalued ...
May 17, 2012 at 04:17 | Source: CNBC
solution to support their Active Cosmetics (La Roche-Posay and Vichy) teams in India. The L’Oreal Active Cosmetics Division focuses on providing solutions to derma-cosmetic problems by offering products in harmony with patient needs, cultures and expectations.
May 23, 2012 at 00:42 | Source: Business Wire
the analyst says. Swiss pharma major Roche had earlier this year signed a manufacturing deal with India's Emcure Pharma so that its anti-cancer drugs Herceptin and MabThera could be made in India at affordable prices. Analysts say Cipla's move ...
May 16, 2012 at 10:23 | Source: MoneyControl.com
"China and India's globalizing economies are paving the way for millions ... will continue to spend very cautiously for some time to come," predicted Roche, who helps direct BCG's Center for Customer and Consumer Insight. To request a summary ...
May 14, 2012 at 03:59 | Source: msnbc.com
INDIA’S pharmaceutical sector ... About three years ago, Cipla had taken on Swiss pharma giant Roche Holdings by launching a generic version of erlotinib at Rs46,000 for a month’s therapy, as against the price Rs140,000 charged by Roche ...
May 14, 2012 at 02:48 | Source: DAWN Group
Following its acquisition, the group changed NL’s name to Nicholas Piramal India Limited. Subsequently, the company continued to grow by acquisitions – a pattern that has been historically followed by the group – acquiring Roche Products India in ...
May 16, 2012 at 04:54 | Source: dealcurry.com
It was moderated by Karen Roche and JT Long of The Energy Report ... in North America went under $2 per thousand cubic feet (Mcf) would apply globally. India is signing $14–$15/Mcf and more; Japan is at $15/Mcf-plus. It’s twice that in ...
May 14, 2012 at 18:54 | Source: Forbes
"Our hope is that the Budget helps position the competitiveness and productivity of the resources sector so we can fend off serious competition to supply huge growth opportunities in India and China." Mr Roche said the Federal Government needed to invest ...
May 7, 2012 at 23:20 | Source: Sunshine Coast Daily